December 2024 FDA Recall Drug by Amerisource Health Services Llc
D-0202-2025 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Amerisource Health Services Llc on December 17, 2024 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0202-2025

Reason for Recall
Failed Dissolution Specifications:
Initiated
12-17-2024
Reported
01-22-2025
Quantity
2,028 units (cartons of 30 individual unit doses)

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Amerisource Health Services LLC
Nationwide in the USA
glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11

Batch or Lot Expiration Information

Lot# 1012910, Exp Date: 04/30/2025